0001209191-22-001712.txt : 20220105 0001209191-22-001712.hdr.sgml : 20220105 20220105163356 ACCESSION NUMBER: 0001209191-22-001712 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220103 FILED AS OF DATE: 20220105 DATE AS OF CHANGE: 20220105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ali-Jackson Kamil CENTRAL INDEX KEY: 0001654337 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37581 FILM NUMBER: 22511635 MAIL ADDRESS: STREET 1: C/O ACLARIS THERAPEUTICS, INC. STREET 2: 101 LINDENWOOD DRIVE, SUITE 400 CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc. CENTRAL INDEX KEY: 0001557746 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460571712 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 640 LEE ROAD STREET 2: SUITE 200 CITY: WAYNE STATE: PA ZIP: 19087 BUSINESS PHONE: 484-324-7933 MAIL ADDRESS: STREET 1: 640 LEE ROAD STREET 2: SUITE 200 CITY: WAYNE STATE: PA ZIP: 19087 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-03 1 0001557746 Aclaris Therapeutics, Inc. ACRS 0001654337 Ali-Jackson Kamil C/O ACLARIS THERAPEUTICS, INC. 640 LEE ROAD, SUITE 200 WAYNE PA 19087 0 1 0 0 Chief Legal Officer Common Stock 2022-01-03 4 M 0 3875 A 118571 D Common Stock 2022-01-03 4 M 0 27905 A 146476 D Common Stock 2022-01-03 4 M 0 6638 A 153114 D Common Stock 2022-01-03 4 M 0 7100 A 160214 D Restricted Stock Units 2022-01-03 4 M 0 3875 0.00 D Common Stock 3875 0 D Restricted Stock Units 2022-01-03 4 M 0 27905 0.00 D Common Stock 34350 0 D Restricted Stock Unit 2022-01-03 4 M 0 6638 0.00 D Common Stock 19914 0 D Restricted Stock Units 2022-01-03 4 M 0 7100 0.00 D Common Stock 28400 0 D Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Represents the number of restricted stock units that were accelerated by mutual agreement between the Reporting Person and the Issuer. The balance of unvested restricted stock units, if any, were forfeited. The shares underlying these restricted stock units vest in four equal annual installments beginning on February 1, 2019, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. /s/ Mark Ballantyne, Attorney-in-Fact 2022-01-05